DermR Health

We won! Australian Technologies Competition Biotech of the Year! ?? It feels surreal to have DermR Health recognised as a technology with the potential to impact millions of lives. What many may not know is that to reach the finals, each of the 138 semi-finalists had to submit a detailed business plan and go-to-market strategy. This included who we want on our advisory board, how we plan to engage them, our key opinion leaders, and how we’ll activate them. The entire process was reviewed by a panel of VC firms, industry experts, and others with experience in scaling startups. Winning this award is validation that our business plan is strong and our go-to-market strategy is solid. While startup technology is an amazing space, business execution is where many fail. I’m incredibly grateful for the educational support from Cicada Innovations, MedTech Actuator, The BridgeTech Program courses. The Department of Health (WA Health) The #Challenge - which gave us crucial insights into clinical workflows and hospital access, all of which informed our business plan. A special thank you to Jenny Aiken, who years ago taught me the importance of being very specific in a go-to-market strategy. Even though it feels like everything is happening at once for us, this is just 1% of the work behind DermR Health. A HUGE thank you to our team CPO Chris Short, Biomedical Engineer Bradman Marks, Biotechnoligst Kilo. H N. and Expert Jaret Lee for their countless hours and dedication, especially on weekends. Lastly, I want to thank every partner and institution who believed in us, put their reputation on the line, and supported a technology with no precedents—just a shared belief that the way skin cancer is diagnosed must change. #DermR #Biotech #AustralianTechnologiesCompetition #Innovation #Startup #SkinCancer #Medtech

?? Exciting News from DermR Health! ?? DermR Health has been named a finalist in the Australian Technologies Competition! This recognition brings us one step closer to potentially being named Australian Technology Company of the Year. ???? Thank you for the continuous support from our team, partners, and everyone who believes in our mission. This milestone is not just a testament to our commitment but also a step forward in our journey to transform skin cancer practices and achieve of goal of preventing 1 billion avoidable skin biopsies. Cicada Innovations

Stefan Mazy is the Founder and CEO of DermR Health, who are on a mission to transform skin cancer detection by replacing painful biopsies with a simple, non-invasive patch. Currently, over 1 billion biopsies are performed worldwide, however over 40% of skin biopsies are benign, and can be avoided. The DermR Patch offers a solution that is accessible to all. By combining innovative device technology with advanced diagnostics, the DermR Patch requires only a minimal cell sample, and can be performed by any genomics-enabled pathology providers to detect a spectrum of skin cancers, such as melanoma. In his Tech23 talk, Stefan highlighted how DermR’s solution addresses critical healthcare needs in remote and Indigenous communities. “The Western Australian Government's new Pilbara Challenge, [allowed us] the opportunity to go on country to smaller Indigenous communities of 200 people, gaining insights into the challenges and limitations of remote healthcare delivery.” Supported by the Department of Health (WA Health) and the Pilbara Aboriginal Health Alliance - PAHA, DermR accelerated its development timeline by over 2.5 years, demonstrating the impact of transforming regional healthcare. Watch Stefan’s full insights on the transformative power of deep tech in the dermatology sector: https://lnkd.in/gq4aqWdn And stay up-to-date with our Tech23 here:?https://lnkd.in/gAxNCxz2 #skincancer #innovatioontech #deeptech #innovation #pilbarachallenge #indigenoushealth #healthcareaccess ?#CxT23 #tech #deeptech #techfestival #australianstartups

?? Come Shift the Mindset In Medicine with us at Cicada x Tech23! ?? Join us at Cicada x Tech23 as we ask how deep tech innovations can shift the medical model from cure to prevention – from treating disease to preemptive, holistic health for everyone. Incredible opportunities exist for innovation in medicine, such as advanced diagnostic tools, robotic systems, personalised treatment technologies, and next-generation drug delivery methods. But what if we shifted our thinking to address the root cause of our problems?? From treating diseases to preventing them, from cure-alls to health for all - we might transform the healthcare system to one that truly focuses on efficiency and accessibility and one tailored to individual needs. Meet the companies featured at Cicada x Tech23 who are helping make that shift: ? ShanShan Wang, CEO and Founder of Roam Technologies (roamtech.ai) is designing a portable oxygen concentrator (iPOC) called JUNO. ? Sylvia C., Director and Co-Founder of OminiWell Pty Ltd,? who are developing a BioTwin Chip to deliver precise cancer treatment solutions via an in vitro cell culture device capable of cultivating patient tumour tissues outside the body. ? Ali Fathi, CTO and Founder of Tetratherix, who have developed the first biostealth fluid matrix to disrupt regenerative medicine and targeted mRNA delivery. ?Stefan Mazy, CEO and Founder of DermR Health Solutions, is designing a world-first microneedle patch that painlessly collects skin cells and screens across the spectrum of skin cancers. ? Chris Jeffery, CEO & Co-Founder of Convergence Medical, is developing the world’s first arthroscopic robot to replace outdated and unreliable arthroscopy equipment.?? ? Don’t miss out on this opportunity to be in the room at Cicada x Tech23 ???? Date & Time: Wednesday, 7th August 2024 ??? Where: Doltone House, Jones Bay Wharf ???? Secure your place now and be part of Australia’s premier deep tech festival.? https://lnkd.in/geeeK8ND #CxT23 #deeptech #innovation #medicine #tech #healthcare #healthstartups #techstartups #techinnovation #techfestival

??Did you know that 40% of skin cancer biopsies are benign and could be avoided? We're thrilled to introduce ???????????? ????????????'s??CEO, Stefan Mazy, one of the pioneering participants of our ?????????????????????? event on ???? ???????? ????????! ?????????? ???????????? is revolutionising ?????????? ???????????? ?????????????????????? with the DermR? Patch, a world-first microneedle device that painlessly collects live skin cells for rapid genomic analysis. This innovative patch can be easily tested against their proprietary RNA Gene Assay which measures ?? ???????? ???????????????????? and can detect ?? ?????????????????? ?????????????? in just a few cells, screening against the spectrum of skin cancers, including Melanoma. DermR? Patch also supports Next-Gen Sequencing for full ?????????? ???????????? ????????????????, opening new avenues for research into hundreds of other diseases, setting new standards in dermatology and beyond. Join us at ?????????????????????? to witness ?????????? ????????????'s CEO, Stefan Mazy, and other groundbreaking startups sharing the latest industrial trends and their innovative journeys? ???????????????? ???????? ? https://lnkd.in/g3fpQgBB ?? ?????????????????????????? ???????????????????? ???????????? ???????????? (?????? ????????????) ?? ???????? ????, ???????? #BioBeacon #2024ARCSAnnualConference #Biotechnology #Innovation #Startups #DermRHealth #SkinCancer #GeneAnalysis #ARCSAustralia #ScientificResearch #HealthTech #MedTech #Pharmaceuticals #Transformation